Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.46 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25476191 | 0.89 | NPC1 (0.46) | ALDH1A1SMN1; SMN2CA1CA2CA12 | |
| SCHEMBL17578250 | 0.85 | MEN1 (0.48) | ALDH1A1SMN1; SMN2TSHRKMT2AKDM4E | |
| SCHEMBL20908982 | 0.84 | KLF10 (0.50) | CA1CA2CA12CA9KMT2A | |
| SCHEMBL19756060 | 0.83 | CYP4F2 (0.40) | CYP4F2CYP4A11ALDH1A1SMN1; SMN2CA1 | |
| SCHEMBL25476195 | 0.83 | NPC1 (0.38) | ALDH1A1TSHRKMT2AKDM4EMEN1 | |
| SCHEMBL25476200 | 0.83 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2TSHRKMT2AKDM4E | |
| SCHEMBL25527926 | 0.83 | CYP4F2 (0.40) | CYP4F2CYP4A11ALDH1A1SMN1; SMN2CA1 | |
| SCHEMBL25476209 | 0.82 | MEN1 (0.48) | ALDH1A1SMN1; SMN2TSHRKMT2AKDM4E | |
| SCHEMBL25476179 | 0.81 | SERPINE1 (0.51) | ALDH1A1CA1CA2TSHRCA12 | |
| SCHEMBL25737057 | 0.81 | CYP4F2 (0.47) | CYP4F2CYP4A11ALDH1A1SMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230161255-A1 | POSITIVE RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-25 | — | — | US | disclosed |
| US-10968175-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-04-06 | — | — | US | disclosed |
| US-20190113843-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10968175-B2 | Resist composition and patterning process | HNRNPU, BRWD1, BICRA | CYP4F2 4789/4885CYP4A11 4557/4885ALDH1A1 4620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.